Results 121 to 130 of about 18,687 (213)

Mutational scan of self-cleavage by HIV-1 protease provides new views of a conformationally dynamic mechanism. [PDF]

J Virol
Nachum GS, Boucher JI, Flynn JM, Quansah P, Nachum S, Bolon DNA.   +5 more
europepmc   +1 more source

Resource Use and Cost Associated With Cardiovascular, Renal, Bone, and Neuropsychiatric Comorbidities in People With HIV in Spain. [PDF]

J Health Econ Outcomes Res
Ventayol P, Dueñas C, Martín C, Castro A, Citoler B, Vidal-Vilar N.   +5 more
europepmc   +1 more source

Highly Potent Phosphinic HIV‑1 Protease Inhibitors: Synthesis, In Vitro Evaluation, and Docking Studies. [PDF]

ACS Omega
Hayat K, Qiu D, Wang Y, Imbenzi PS, Khan FI, Matziari M.   +5 more
europepmc   +1 more source

The dolutegravir failure cohort: A multi-country longitudinal cohort with a randomised clinical trial of continued dolutegravir versus switch to darunavir in people with viraemia while on dolutegravir in Sub-Saharan Africa (The Ndovu Study) protocol. [PDF]

PLoS One
Ombajo LA, Nkuranga J, Penner J, Kamau EW, Ismael N, Munseri P, Ayakaka I, Labhardt N, Wamalwa D, Ramgi P, Chissumba RM, Wagude J, Bakari M, Omodi V, Otieno E, Abuogi L, Patel R, Opondo C, Grint D, King'wara L, Macharia A, Mulwa A, Amoth P, Ndovu study group.   +23 more
europepmc   +1 more source

To Switch or not to Switch: are there any Antiretroviral Strategies to Attenuate Weight Gain in People with HIV? [PDF]

Curr HIV/AIDS Rep
Debroy P, Lake JE.
europepmc   +1 more source

Regional Variations of Rates and Determinants of Drug Resistance Mutations in People Failing First-line Therapy for HIV-1: A Substudy from the D2EFT Phase 3b/4 Clinical Trial. [PDF]

Clin Infect Dis
Obeng BM, Hutchinson J, Shaik A, Chetchotisakd P, Azwa I, Wulan WN, Kumarasamy N, Wolff M, Bruguera J, Losso M, Kaplan R, Diallo MS, Eriobu N, Musoro G, Kumalawati J, Badamasi A, Fitriah M, Mulya DP, Law M, Matthews G, Di Giallonardo F, Kelleher AD, Dolutegravir and Darunavir Evaluation in Adults Failing Therapy (D2EFT) Study Group .   +22 more
europepmc   +1 more source

2025 US Public Health Service Guidelines for the Management of Occupational Exposures to Human Immunodeficiency Virus and Recommendations for Post-exposure Prophylaxis in Healthcare Settings. [PDF]

Infect Control Hosp Epidemiol
Kofman AD, Struble KA, Heneine W, Gayle B, de Perio MA, Okasako-Schmucker DL, So CN, Anderson LE, Stone EC, Henderson DK, Kuhar DT.   +10 more
europepmc   +1 more source

Handbook of drug-nutrient interactions [PDF]

, 2009

core   +1 more source

Effectiveness of simplified ART regimens in older adults living with HIV: real-world evidence from a Brazilian cohort. [PDF]

Braz J Med Biol Res
Stanicki PV, Tasca KI, Zimmerman WR, Barbosa AN.   +3 more
europepmc   +1 more source

Inflammatory, procoagulant markers and HIV residual viremia in patients receiving protease inhibitor monotherapy or triple drug therapy: a cross-sectional study [PDF]

, 2014
Francisco Xavier Zamora, Ignacio Pérez-Valero, Jesús Mingorance, Jose Ignacio Bernardino, José Ramón Arribas, Juan Julián González-García, Maria Luisa Montes, Miriam Estébanez, Natalia Stella-Ascariz   +8 more
core   +1 more source